A new national guideline provides evidence-based recommendations for diagnosing, treating, and preventing pediatric ...

Parents are being warned to look out for symptoms of Respiratory Syncytial Virus (RSV) in their newborn babies as the NHS prepares for overcrowding this winter. The infection causes mild, cold ...

Parents are being warned to look out for symptoms of Respiratory Syncytial Virus (RSV) in their newborn babies as the NHS prepares for overcrowding this winter.. The infection causes mild, cold ...

Respiratory syncytial virus, or RSV, is a respiratory virus that infects the lungs and breathing passages. Healthy people typically experience mild, cold-like symptoms and recover in a week or two.

THURSDAY, June 12, 2025 (HealthDay News) — A newly approved shot could soon help protect babies from respiratory syncytial ...

U.S. FDA Approves Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Born During or Entering Their First RSV ...

In a major boost for infant health, the U.S. Food and Drug Administration (FDA) has approved ENFLONSIA ™ (clesrovimab-cfor), ...

It starts with a sniffle. A mild cough. You tell yourself it’s just a cold—babies get those, right? But make no mistake. RSV ...

Each year, on November 12, we observe World Pneumonia Day to raise awareness about one of the most serious and often ...

Parents are being warned to look out for symptoms of Respiratory Syncytial Virus (RSV) in their newborn babies as the NHS prepares for overcrowding this winter. The infection causes mild, cold ...

RAHWAY, N.J., June 09, 2025--U.S. FDA Approves Merck’s ENFLONSIA for Prevention of RSV Lower Respiratory Tract Disease in Infants Born During or Entering Their First RSV Season ...